Cargando…

Outcome quality standards in advanced ovarian cancer surgery

INTRODUCTION: Advanced ovarian cancer surgery (AOCS) frequently results in serious postoperative complications. Because managing AOCS is difficult, some standards need to be established that allow surgeons to assess the quality of treatment provided and consider what aspects should improve. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Llueca, Antoni, Serra, Anna, Climent, Maria Teresa, Segarra, Blanca, Maazouzi, Yasmine, Soriano, Marta, Escrig, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690155/
https://www.ncbi.nlm.nih.gov/pubmed/33239057
http://dx.doi.org/10.1186/s12957-020-02064-7
_version_ 1783614011386888192
author Llueca, Antoni
Serra, Anna
Climent, Maria Teresa
Segarra, Blanca
Maazouzi, Yasmine
Soriano, Marta
Escrig, Javier
author_facet Llueca, Antoni
Serra, Anna
Climent, Maria Teresa
Segarra, Blanca
Maazouzi, Yasmine
Soriano, Marta
Escrig, Javier
author_sort Llueca, Antoni
collection PubMed
description INTRODUCTION: Advanced ovarian cancer surgery (AOCS) frequently results in serious postoperative complications. Because managing AOCS is difficult, some standards need to be established that allow surgeons to assess the quality of treatment provided and consider what aspects should improve. This study aimed to identify quality indicators (QIs) of clinical relevance and to establish their acceptable quality limits (i.e., standard) in AOCS. MATERIALS AND METHODS: We performed a systematic search on clinical practice guidelines, consensus conferences, and reviews on the outcome and quality of AOCS to identify which QIs have clinical relevance in AOCS. We then searched the literature (from January 2006 to December 2018) for each QI in combination with the keywords of advanced ovarian cancer, surgery, outcome, and oncology. Standards for each QI were determined by statistical process control techniques. The acceptable quality limits for each QI were defined as being within the limits of the 99.8% interval, which indicated a favorable outcome. RESULTS: A total of 38 studies were included. The QIs selected for AOCS were complete removal of the tumor upon visual inspection (complete cytoreductive surgery), a residual tumor of < 1 cm (optimal cytoreductive surgery), a residual tumor of > 1 cm (suboptimal cytoreductive surgery), major morbidity, and 5-year survival. The rates of complete cytoreductive surgery, optimal cytoreductive surgery, suboptimal cytoreductive surgery, morbidity, and 5-year survival had quality limits of < 27%, < 23%, > 39%, > 33%, and < 27%, respectively. CONCLUSION: Our results provide a general view of clinical indicators for AOCS. Acceptable quality limits that can be considered as standards were established.
format Online
Article
Text
id pubmed-7690155
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76901552020-11-30 Outcome quality standards in advanced ovarian cancer surgery Llueca, Antoni Serra, Anna Climent, Maria Teresa Segarra, Blanca Maazouzi, Yasmine Soriano, Marta Escrig, Javier World J Surg Oncol Review INTRODUCTION: Advanced ovarian cancer surgery (AOCS) frequently results in serious postoperative complications. Because managing AOCS is difficult, some standards need to be established that allow surgeons to assess the quality of treatment provided and consider what aspects should improve. This study aimed to identify quality indicators (QIs) of clinical relevance and to establish their acceptable quality limits (i.e., standard) in AOCS. MATERIALS AND METHODS: We performed a systematic search on clinical practice guidelines, consensus conferences, and reviews on the outcome and quality of AOCS to identify which QIs have clinical relevance in AOCS. We then searched the literature (from January 2006 to December 2018) for each QI in combination with the keywords of advanced ovarian cancer, surgery, outcome, and oncology. Standards for each QI were determined by statistical process control techniques. The acceptable quality limits for each QI were defined as being within the limits of the 99.8% interval, which indicated a favorable outcome. RESULTS: A total of 38 studies were included. The QIs selected for AOCS were complete removal of the tumor upon visual inspection (complete cytoreductive surgery), a residual tumor of < 1 cm (optimal cytoreductive surgery), a residual tumor of > 1 cm (suboptimal cytoreductive surgery), major morbidity, and 5-year survival. The rates of complete cytoreductive surgery, optimal cytoreductive surgery, suboptimal cytoreductive surgery, morbidity, and 5-year survival had quality limits of < 27%, < 23%, > 39%, > 33%, and < 27%, respectively. CONCLUSION: Our results provide a general view of clinical indicators for AOCS. Acceptable quality limits that can be considered as standards were established. BioMed Central 2020-11-25 /pmc/articles/PMC7690155/ /pubmed/33239057 http://dx.doi.org/10.1186/s12957-020-02064-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Llueca, Antoni
Serra, Anna
Climent, Maria Teresa
Segarra, Blanca
Maazouzi, Yasmine
Soriano, Marta
Escrig, Javier
Outcome quality standards in advanced ovarian cancer surgery
title Outcome quality standards in advanced ovarian cancer surgery
title_full Outcome quality standards in advanced ovarian cancer surgery
title_fullStr Outcome quality standards in advanced ovarian cancer surgery
title_full_unstemmed Outcome quality standards in advanced ovarian cancer surgery
title_short Outcome quality standards in advanced ovarian cancer surgery
title_sort outcome quality standards in advanced ovarian cancer surgery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690155/
https://www.ncbi.nlm.nih.gov/pubmed/33239057
http://dx.doi.org/10.1186/s12957-020-02064-7
work_keys_str_mv AT lluecaantoni outcomequalitystandardsinadvancedovariancancersurgery
AT serraanna outcomequalitystandardsinadvancedovariancancersurgery
AT climentmariateresa outcomequalitystandardsinadvancedovariancancersurgery
AT segarrablanca outcomequalitystandardsinadvancedovariancancersurgery
AT maazouziyasmine outcomequalitystandardsinadvancedovariancancersurgery
AT sorianomarta outcomequalitystandardsinadvancedovariancancersurgery
AT escrigjavier outcomequalitystandardsinadvancedovariancancersurgery
AT outcomequalitystandardsinadvancedovariancancersurgery